Bogdan A Czerniak, M.D., Ph.D.

Peer-Reviewed Articles

1. Hosseini, H, Alhalabi, O, Guo, CC, Bryan, J, Czerniak, BA, Ramalingam, P, Euscher, ED, Hansel, DE. Pilomatrix-like high-grade carcinoma involving the urinary bladder. Human Pathology Reports 43, 2026. e-Pub 2026.
2. Lee, S, Jung, SY, Kuś, P, Bondaruk, J, Lee, JG, Jaksik, R, Putluri, N, Dinh, KN, Cogdell, D, Chen, H, Wang, Y, Chen, J, Navai, N, Dinney, CP, Mendelsohn, C, McConkey, DJ, Behringer, RR, Guo, CC, Wei, P, Kimmel, M, Czerniak, BA. Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancer. Journal of Pathology 267(3):329-346, 2025. e-Pub 2025. PMID: 40996337.
3. Czerniak BA, Igel DA, Saporito D, Adibi M, Mork M, Ozambela M, Vilar-Sanchez E, Guo C, Czerniak BA, Jonasch E, Matin SF. Genotype-Phenotype Characterization of Lynch Syndrome-associated Upper Tract Urothelial Carcinoma. Eur Urol Oncol S2588-9311(25):00258-5, 2025. PMID: 41176509.
4. Mi W, Zang C, Zhao J, Kamat AM, Wei P, Hansel DE, Czerniak BA, Guo CC. Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinoma. Human Pathology 163:105904, 2025. e-Pub 2025. PMID: 40780614.
5. Shen, Y, Zheng, L, Zhao, J, Wang, Y, Chen, H, Roy Chowdhuri, S, Kamat, A, Alhalabi, O, Gao, J, Siefker-Radtke, AO, Wei, P, Hansel, DE, Czerniak, BA, Guo, CC. Molecular profile of micropapillary urothelial carcinoma of the urinary bladder. Human Pathology 159, 2025. e-Pub 2025. PMID: 40403852.
6. Mokkapati S, Manyam G, Steinmetz AR, Tholomier C, Martini A, Choi W, Czerniak B, Lee BH, Dinney CP, McConkey DJ. Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery. Transl Oncol 52:102269, 2025. e-Pub 2025. PMID: 39808845.
7. Serrano, A, Rocha, P, Freitas Lima, C, Stewart, A, Zhang, B, Diao, L, Fujimoto, J, Cardnell, R, Lu, W, Khan, KB, Sable, B, Ellison, AR, Wistuba, II, Concannon, KF, Halperin, DM, Czerniak, BA, Sircar, K, Zhang, M, Cargill, KR, Wang, Q, Aparicio, A, Lazar, A, Hernandez, S, Estrella, JS, Ramalingam, P, El-Naggar, AK, Kalhor, N, Gay, CM, Byers, LA, Solis Soto, LM. Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558076.
8. Tabet GC, Zheng L, Hosseini H, Ward J, Pisters L, Campbell MT, Tu S, Czerniak B, Guo CC. Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases. Hum Pathol 153, 2024. e-Pub 2024. PMID: 39461379.
9. Czerniak B. Bladder cancer variants - one disease with many faces. Nat Rev Urol 21(9):519-520, 2024. e-Pub 2024. PMID: 38649437.
10. Jiang J, Liu Y, Qin J, Chen J, Wu J, Pizzi MP, Lazcano R, Yamashita K, Xu Z, Pei G, Cho KS, Chu Y, Sinjab A, Peng F, Yan X, Han G, Wang R, Dai E, Dai Y, Czerniak BA, Futreal A, Maitra A, Lazar A, Kadara H, Jazaeri AA, Cheng X, Ajani J, Gao J, Hu J, Wang L. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nat Commun 15(1):7312, 2024. e-Pub 2024. PMID: 39181865.
11. Plumber SA, Tate T, Al-Ahmadie H, Chen X, Choi W, Basar M, Lu C, Viny A, Batourina E, Li J, Gretarsson K, Alija B, Molotkov A, Wiessner G, Lee BHL, McKiernan J, McConkey D, Dinney C, Czerniak B, Mendelsohn CL. Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer. Nat Commun 15(1):6538, 2024. e-Pub 2024. PMID: 39095358.
12. Feng M, Matoso A, Epstein G, Fong M, Park YH, Gabrielson A, Patel S, Czerniak B, Compérat E, Hoffman-Censits J, Kates M, Kim S, McConkey D, Choi W. Identification of Lineage-specific Transcriptional Factor-defined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol 85(6):523-526, 2024. e-Pub 2023. PMID: 37380560.
13. Zheng L, Chen H, Zhao J, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Hansel DE, Czerniak B, Guo CC. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases. Hum Pathol 148:1-6, 2024. e-Pub 2024. PMID: 38679207.
14. Lee S, Bondaruk J, Wang Y, Chen H, Lee JG, Majewski T, Mullen RD, Cogdell D, Chen J, Wang Z, Yao H, Kus P, Jeong J, Lee I, Choi W, Navai N, Guo C, Dinney C, Baggerly K, Mendelsohn C, McConkey D, Behringer RR, Kimmel M, Wei P, Czerniak B. Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesis. Cell Rep 43(5):114146, 2024. e-Pub 2024. PMID: 38676926.
15. Lee S, Jung SY, Kus P, Bondaruk J, Lee J, Jaksik R, Putluri N, Dinh K, Cogdell D, Chen H, Wang Y, Chen J, Nevai N, Dinney C, Mendelsohn C, McConkey D, Behringer R, Guo C, Wei P, Kimmel M, Czerniak B. Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping. Res Sq, 2024. e-Pub 2024. PMID: 38659962.
16. Steinmetz, AR, Pierce, M, Martini, A, Tholomier, C, Manyam, GC, Chen, Y, Sood, A, Duplisea, JJ, Johnson, BA, Czerniak, BA, Lee, B, Jagannath, C, Ylä-Herttuala, S, Parker, NR, McConkey, D, Dinney, CP, Mokkapati, S. Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model. Frontiers in immunology 15, 2024. e-Pub 2024. PMID: 39559365.
17. Moussa, MJ, Chen, AH, Grana, AK, Gao, J, Shah, AY, Corn, P, Tannir, NM, Goswami, S, Wang, J, Araujo, JC, Kamat, A, Navai, N, Pettaway, CA, Adibi, M, Czerniak, BA, Guo, CC, Siefker-Radtke, AO, Campbell, M, Alhalabi, O. Clinical outcomes of frontline GemFLP in advanced urachal and non-urachal adenocarcinomas of the urinary tract. Journal of Clinical Oncology 42(4), 2024. e-Pub 2024.
18. Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AO. Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol 6(6):611-620, 2023. e-Pub 2023. PMID: 37833193.
19. Tate T, Plumber SA, Al-Ahmadie H, Chen X, Choi W, Lu C, Viny A, Batourina E, Gartensson K, Alija B, Molotkov A, Wiessner G, McKiernan J, McConkey D, Dinney C, Czerniak B, Mendelsohn CL. Combined Mek inhibition and Pparg activation Eradicates Muscle Invasive Bladder cancer in a Mouse Model of BBN-induced Carcinogenesis. bioRxiv, 2023. e-Pub 2023.
20. Gangahar CN, Dehner CA, Wang DP, Amini B, Hillen T, O'Conor C, Jennings SN, Byrnes K, Montgomery EA, Czerniak BA, Bridge JA, Schroeder MC, Jennings JW, Wang WL, Chrisinger JSA. Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases. Histopathology 83(1):40-48, 2023. e-Pub 2023. PMID: 37099409.
21. Wang Z, Czerniak B, Wei P. Spatial IMIX: A Mixture Model Approach to Spatially Correlated Multi-Omics Data Integration. bioRxiv, 2023. e-Pub 2023.
22. Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol 6(2):228-232, 2023. e-Pub 2021. PMID: 34789422.
23. Guo CC, Shen SS, Czerniak B. Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors. Bladder Cancer 9(1):1-14, 2023. e-Pub 2023. PMID: 38994481.
24. Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang W. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. Nat Biotechnol 40(11):1624-1633, 2022. e-Pub 2022. PMID: 35697807.
25. Labbate CV, Hensley PJ, Miest TS, Qiao W, Adibi M, Shah AY, Chery L, Papadopoulos J, Siefker-Radtke AO, Gao J, Guo CC, Czerniak BA, Navai N, Kamat AM, Dinney CP, Campbell MT, Matin SF. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol 40(10):454.e17-454.e23, 2022. e-Pub 2022. PMID: 35961847.
26. Mokkapati S, Narayan VM, Manyam GC, Lim AH, Duplisea JJ, Kokorovic A, Miest TS, Mitra AP, Plote D, Anand SS, Metcalfe MJ, Dunner K, Johnson BA, Czerniak BA, Nieminen T, Heikura T, Yla-Herttuala S, Parker NR, Schluns KS, McConkey DJ, Dinney CP. Lentiviral interferon: A novel method for gene therapy in bladder cancer. Mol Ther Oncolytics 26:141-157, 2022. e-Pub 2022. PMID: 35847448.
27. Zaleski MP, Chen H, Roy-Chowdhuri S, Patel KP, Luthra R, Routbort MJ, Kamat AM, Gao J, Siefker-Radtke A, Czerniak B, Guo CC. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma. Am J Clin Pathol 158(2):263-269, 2022. e-Pub 2022. PMID: 35467000.
28. Bondaruk J, Jaksik R, Wang Z, Cogdell D, Lee S, Chen Y, Dinh KN, Majewski T, Zhang L, Cao S, Tian F, Yao H, Kus P, Chen H, Weinstein JN, Navai N, Dinney C, Gao J, Theodorescu D, Logothetis C, Guo CC, Wang W, McConkey D, Wei P, Kimmel M, Czerniak B. The origin of bladder cancer from mucosal field effects. iScience 25(7):104551, 2022. e-Pub 2022. PMID: 35747385.
29. Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao J. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nat Commun 13(1):1797, 2022. e-Pub 2022. PMID: 35379845.
30. Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol 46(1):11-17, 2022. e-Pub 2021. PMID: 34334690.
31. Han G, Yang G, Hao D, Lu Y, Thein K, Simpson BS, Chen J, Sun R, Alhalabi O, Wang R, Dang M, Dai E, Zhang S, Nie F, Zhao S, Guo C, Hamza A, Czerniak B, Cheng C, Siefker-Radtke A, Bhat K, Futreal A, Peng G, Wargo J, Peng W, Kadara H, Ajani J, Swanton C, Litchfield K, Ahnert JR, Gao J, Wang L. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun 12(1):5606, 2021. e-Pub 2021. PMID: 34556668.
32. Zhou X, Kurywchak P, Wolf-Dennen K, Che SPY, Sulakhe D, D'Souza M, Xie B, Maltsev N, Gilliam TC, Wu CC, McAndrews KM, LeBleu VS, McConkey DJ, Volpert OV, Pretzsch SM, Czerniak BA, Dinney CP, Kalluri R. Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer. Mol Ther Methods Clin Dev 22:360-376, 2021. e-Pub 2021. PMID: 34514028.
33. Petros FG, Choi W, Qi Y, Moss T, Li R, Su X, Guo CC, Czerniak B, Dinney C, McConkey DJ, Matin SF. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. J Urol 206(3):548-557, 2021. e-Pub 2021. PMID: 33881933.
34. Wang G, Black PC, Goebell PJ, Ji L, Cordon-Cardo C, Schmitz-Dräger B, Hawes D, Czerniak B, Minner S, Sauter G, Waldman F, Groshen S, Cote RJ, Dinney CP. Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project. Urol Oncol 39(5):301.e17-301.e28, 2021. e-Pub 2021. PMID: 33563539.
35. Callan AK, Singleterry S, Czerniak BA, Selber JC, Satcher RL. Total Tibial Allograft Reconstruction for Adamantinoma: A Case Report With 2-Year Follow-up. JBJS Case Connect 10(4):e20.00046, 2020. e-Pub 2020. PMID: 33449546.
36. Tu MM, Abdel-Hafiz HA, Jones RT, Jean A, Hoff KJ, Duex JE, Chauca-Diaz A, Costello JC, Dancik GM, Tamburini BAJ, Czerniak B, Kaye J, Theodorescu D. Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy. Commun Biol 3(1):720, 2020. e-Pub 2020. PMID: 33247183.
37. Hamza A, Hwang MJ, Czerniak BA, Guo CC. Secondary tumors of the bladder: A survival outcome study. Ann Diagn Pathol 48:151593, 2020. e-Pub 2020. PMID: 32836180.
38. Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, Group MC, working group PNSMCM, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L, Consortium P. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun 11(1):4748, 2020. e-Pub 2020. PMID: 32958763.
39. Li CH, Prokopec SD, Sun RX, Yousif F, Schmitz N, Subtypes PT, Translation C, Boutros PC, Consortium P. Sex differences in oncogenic mutational processes. Nat Commun 11(1):4330, 2020. e-Pub 2020. PMID: 32859912.
40. Hwang MJ, Kamat AM, Dinney CP, Czerniak B, Guo CC. Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens. Am J Clin Pathol 154(2):208-214, 2020. e-Pub 2020. PMID: 32253420.
41. Yang G, Bondaruk J, Cogdell D, Wang Z, Lee S, Lee JG, Zhang S, Choi W, Wang Y, Liang Y, Wang G, Wang Y, Yao H, Dadhania V, Gao J, Logothetis C, Siefker-Radtke A, Kamat A, Dinney C, Theodorescu D, Kimmel M, Wei P, Guo CC, Weinstein JN, McConkey DJ, Czerniak B. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer. iScience 23(6):101201, 2020. e-Pub 2020. PMID: 32521509.
42. Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak B. Assessment of Luminal and Basal Phenotypes in Bladder Cancer. Sci Rep 10(1):9743, 2020. e-Pub 2020. PMID: 32546765.
43. Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Mol Cancer Res 18(6):811-821, 2020. e-Pub 2020. PMID: 32122956.
44. Alakeel F, Al Sannaa G, Ibarra-Cortez SH, Reardon MJ, Czerniak B, Chan EY, Ro J. Cardiac paragangliomas: A case series with clinicopathologic features and succinate dehydrogenase B immunostaining. Ann Diagn Pathol 45:151477, 2020. e-Pub 2020. PMID: 32062474.
45. Rubanova Y, Shi R, Harrigan CF, Li R, Wintersinger J, Sahin N, Deshwar AG, Evolution P, Group HW, Morris QD, Consortium P. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Commun 11(1):731, 2020. e-Pub 2020. PMID: 32024834.
46. Sieverling L, Hong C, Koser SD, Ginsbach P, Kleinheinz K, Hutter B, Braun DM, Cortés-Ciriano I, Xi R, Kabbe R, Park PJ, Eils R, Schlesner M, Working Group PV, Brors B, Rippe K, Jones DTW, Feuerbach L, Consortium P. Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun 11(1):733, 2020. e-Pub 2020. PMID: 32024817.
47. Shuai S, Drivers P, Working Group FI, Gallinger S, Stein LD, Consortium P. Combined burden and functional impact tests for cancer driver discovery using DriverPower. Nat Commun 11(1):734, 2020. e-Pub 2020. PMID: 32024818.
48. Cmero M, Yuan K, Ong CS, Schröder J, Evolution P, Group HW, Corcoran NM, Papenfuss T, Hovens CM, Markowetz F, Macintyre G, Consortium P. Inferring structural variant cancer cell fraction. Nat Commun 11(1):730, 2020. e-Pub 2020. PMID: 32024845.
49. Jiao W, Atwal G, Polak P, Karlic R, Cuppen E, Subtypes PT, Working Group CT, Danyi A, de Ridder J, van Herpen C, Lolkema MP, Steeghs N, Getz G, Morris QD, Stein LD, Consortium P. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat Commun 11(1):728, 2020. e-Pub 2020. PMID: 32024849.
50. Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, Mee MW, Boutros PC, Drivers P, Working Group FI, Reimand J, Consortium P. Integrative pathway enrichment analysis of multivariate omics data. Nat Commun 11(1):735, 2020. e-Pub 2020. PMID: 32024846.
51. Zhang Y, Chen F, Fonseca NA, He Y, Fujita M, Nakagawa H, Zhang Z, Brazma A, Working Group PT, Working Group PSV, Creighton CJ, Consortium P. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations. Nat Commun 11(1):736, 2020. e-Pub 2020. PMID: 32024823.
52. Bhandari V, Li CH, Bristow RG, Boutros PC, Consortium P. Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat Commun 11(1):737, 2020. e-Pub 2020. PMID: 32024819.
53. Reyna MA, Haan D, Paczkowska M, Verbeke LPC, Vazquez M, Kahraman A, Pulido-Tamayo S, Barenboim J, Wadi L, Dhingra P, Shrestha R, Getz G, Lawrence MS, Pedersen JS, Rubin MA, Wheeler DA, Brunak S, Izarzugaza JMG, Khurana E, Marchal K, von Mering C, Sahinalp SC, Valencia A, Drivers P, Working Group FI, Reimand J, Stuart JM, Raphael BJ, Consortium P. Pathway and network analysis of more than 2500 whole cancer genomes. Nat Commun 11(1):729, 2020. e-Pub 2020. PMID: 32024854.
54. Genomes Consortium IPAOW. Pan-cancer analysis of whole genomes. Nature 578(7793):82-93, 2020. e-Pub 2020. PMID: 32025007.
55. Carlevaro-Fita J, Lanzós A, Feuerbach L, Hong C, Mas-Ponte D, Pedersen JS, Drivers P, Group FI, Johnson R, Consortium P. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun Biol 3(1):56, 2020. e-Pub 2020. PMID: 32024996.
56. Herling CD, Coombes KR, Benner A, Bloehdorn J, Barron LL, Abrams ZB, Majewski T, Bondaruk JE, Bahlo J, Fischer K, Hallek M, Stilgenbauer S, Czerniak BA, Oakes CC, Ferrajoli A, Keating MJ, Abruzzo LV. Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Lancet Oncol. e-Pub 2019. PMID: 31582354.
57. Kamoun A, de Reyniès A, Allory Y, Sjödahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskjøt L, Höglund M, Lerner SP, Real FX, Radvanyi F, Taxonomy Group BCM. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol. e-Pub 2019. PMID: 31563503.
58. Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma. Urol Oncol 37(6):354.e19-354.e26, 2019. e-Pub 2019. PMID: 30777393.
59. Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep 27(6):1781-1793.e4, 2019. e-Pub 2019. PMID: 31067463.
60. Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W, Dinney C, Grossman HB, Logothetis C, Scherer SE, Guo CC, Zhang L, Wei P, Weinstein JN, Issa JP, Baggerly K, McConkey DJ, Czerniak B. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Rep 26(8):2241-2256.e4, 2019. e-Pub 2019. PMID: 30784602.
61. Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB, Research Network CGA, Camargo F, Liang H. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep 25(5):1304-1317.e5, 2018. e-Pub 2018. PMID: 30380420.
62. Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z, Hansel D, de Velasco G, Pennathur A, Andersen JB, O'Rourke CJ, Ohshiro K, Jogunoori W, Nguyen BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W, Zhang J, Tong P, Cherniack AD, Deng C, Resar L, Research Network CGA, Weinstein JN, Mishra L, Akbani R. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Syst 7(4):422-437.e7, 2018. e-Pub 2018. PMID: 30268436.
63. Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Research Network CGA, Rätsch G. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34(2):211-224.e6, 2018. e-Pub 2018. PMID: 30078747.
64. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Network TR, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 174(4):1033, 2018. e-Pub 2018. PMID: 30096301.
65. Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Small cell carcinoma of the urinary bladder: a Clinicopathologic and Immunohistochemical analysis of 81 cases. Hum Pathol. e-Pub 2018. PMID: 29763719.
66. Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE, Research Network CGA, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich L. The Immune Landscape of Cancer. Immunity 48(4):812-830.e14, 2018. e-Pub 2018. PMID: 29628290.
67. Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Research Network CGA, Thorsson V, Bass AJ, Laird PW. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33(4):721-735.e8, 2018. e-Pub 2018. PMID: 29622466.
68. Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang Y, Jia L, Li S, Research Network CGA, Xie W, Yang D. lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell 33(4):706-720.e9, 2018. e-Pub 2018. PMID: 29622465.
69. Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, Liu Y, Fan H, Shen H, Ravikumar V, Rao A, Schultz A, Li X, Sumazin P, Williams C, Mestdagh P, Gunaratne PH, Yau C, Bowlby R, Robertson AG, Tiezzi DG, Wang C, Cherniack AD, Godwin AK, Kuderer NM, Rader JS, Zuna RE, Sood AK, Lazar AJ, Ojesina AI, Adebamowo C, Adebamowo SN, Baggerly KA, Chen TW, Chiu HS, Lefever S, Liu L, MacKenzie K, Orsulic S, Roszik J, Shelley CS, Song Q, Vellano CP, Wentzensen N, Research Network CGA, Weinstein JN, Mills GB, Levine DA, Akbani R. A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33(4):690-705.e9, 2018. e-Pub 2018. PMID: 29622464.
70. Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, Lazar AJ, Research Network CGA, Cherniack AD, Beroukhim R, Meyerson M. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell 33(4):676-689.e3, 2018. e-Pub 2018. PMID: 29622463.
71. Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Research Network CGA, Hu H. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell 173(2):400-416.e11, 2018. e-Pub 2018. PMID: 29625055.
72. Chen H, Li C, Peng X, Zhou Z, Weinstein JN, Research Network CGA, Liang H. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell 173(2):386-399.e12, 2018. e-Pub 2018. PMID: 29625054.
73. Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, Group MC, Research Network CGA, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 173(2):371-385.e18, 2018. e-Pub 2018. PMID: 29625053.
74. Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Research Network CGA, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L. Pathogenic Germline Variants in 10,389 Adult Cancers. Cell 173(2):355-370.e14, 2018. e-Pub 2018. PMID: 29625052.
75. Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwinska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin AK, Lazar AJ, Research Network CGA, Stuart JM, Hoadley KA, Laird PW, Noushmehr H, Wiznerowicz M. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173(2):338-354.e15, 2018. e-Pub 2018. PMID: 29625051.
76. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z, Ochoa A, Gross B, Gao J, Zhang H, Kundra R, Kandoth C, Bahceci I, Dervishi L, Dogrusoz U, Zhou W, Shen H, Laird PW, Way GP, Greene CS, Liang H, Xiao Y, Wang C, Iavarone A, Berger AH, Bivona TG, Lazar AJ, Hammer GD, Giordano T, Kwong LN, McArthur G, Huang C, Tward AD, Frederick MJ, McCormick F, Meyerson M, Research Network CGA, Van Allen EM, Cherniack AD, Ciriello G, Sander C, Schultz N. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell 173(2):321-337.e10, 2018. e-Pub 2018. PMID: 29625050.
77. Ding L, Bailey MH, Porta-Pardo E, Thorsson V, Colaprico A, Bertrand D, Gibbs DL, Weerasinghe A, Huang KL, Tokheim C, Cortés-Ciriano I, Jayasinghe R, Chen F, Yu L, Sun S, Olsen C, Kim J, Taylor AM, Cherniack AD, Akbani R, Suphavilai C, Nagarajan N, Stuart JM, Mills GB, Wyczalkowski MA, Vincent BG, Hutter CM, Zenklusen JC, Hoadley KA, Wendl MC, Shmulevich L, Lazar AJ, Wheeler DA, Getz G, Research Network CGA. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics. Cell 173(2):305-320.e10, 2018. e-Pub 2018. PMID: 29625049.
78. Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Atlas Network CG, Stuart JM, Benz CC, Laird PW. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173(2):291-304.e6, 2018. e-Pub 2018. PMID: 29625048.
79. Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP, Hsieh JJ, Ho TH, Kanchi RS, Krishnan B, Kwaitkowski DJ, Lui W, Merino MJ, Mills GB, Myers J, Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheeler DA, Yang L, Kim WT, Robertson AG, Research Network CGA, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep 23(1):313-326.e5, 2018. e-Pub 2018. PMID: 29617669.
80. Chiu HS, Somvanshi S, Patel E, Chen TW, Singh VP, Zorman B, Patil SL, Pan Y, Chatterjee SS, Research Network CGA, Sood AK, Gunaratne PH, Sumazin P. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Rep 23(1):297-312.e12, 2018. e-Pub 2018. PMID: 29617668.
81. Seiler M, Peng S, Agrawal AA, Palacino J, Teng T, Zhu P, Smith PG, Research Network CGA, Buonamici S, Yu L. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. Cell Rep 23(1):282-296.e4, 2018. e-Pub 2018. PMID: 29617667.
82. Jayasinghe RG, Cao S, Gao Q, Wendl MC, Vo NS, Reynolds SM, Zhao Y, Climente-González H, Chai S, Wang F, Varghese R, Huang M, Liang WW, Wyczalkowski MA, Sengupta S, Li Z, Payne SH, Fenyö D, Miner JH, Walter MJ, Research Network CGA, Vincent B, Eyras E, Chen K, Shmulevich I, Chen F, Ding L. Systematic Analysis of Splice-Site-Creating Mutations in Cancer. Cell Rep 23(1):270-281.e3, 2018. e-Pub 2018. PMID: 29617666.
83. Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi PL, Wang Y, Cheng F, Tan L, Mojumdar K, Du D, Ge Z, Li J, Thomas GV, Birsoy K, Liu L, Zhang H, Zhao Z, Marchand C, Weinstein JN, Research Network CGA, Bathe OF, Liang H. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep 23(1):255-269.e4, 2018. e-Pub 2018. PMID: 29617665.
84. Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Research Network CGA, Monnat RJ, Xiao Y, Wang C. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 23(1):239-254.e6, 2018. e-Pub 2018. PMID: 29617664.
85. Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Working Group FA, Research Network CGA, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep 23(1):227-238.e3, 2018. e-Pub 2018. PMID: 29617662.
86. Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, Research Network CGA, Piwnica-Worms H, Ma L, Liang H. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep 23(1):213-226.e3, 2018. e-Pub 2018. PMID: 29617661.
87. Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Research Network CGA, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep 23(1):194-212.e6, 2018. e-Pub 2018. PMID: 29617660.
88. Saltz J, Gupta R, Hou L, Kurc T, Singh P, Nguyen V, Samaras D, Shroyer KR, Zhao T, Batiste R, Van Arnam J, Research Network CGA, Shmulevich I, Rao AUK, Lazar AJ, Sharma A, Thorsson V. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. Cell Rep 23(1):181-193.e7, 2018. e-Pub 2018. PMID: 29617659.
89. Way GP, Sanchez-Vega F, La K, Armenia J, Chatila WK, Luna A, Sander C, Cherniack AD, Mina M, Ciriello G, Schultz N, Research Network CGA, Sanchez Y, Greene CS. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep 23(1):172-180.e3, 2018. e-Pub 2018. PMID: 29617658.
90. Schaub FX, Dhankani V, Berger AC, Trivedi M, Richardson AB, Shaw R, Zhao W, Zhang X, Ventura A, Liu Y, Ayer DE, Hurlin PJ, Cherniack AD, Eisenman RN, Bernard B, Grandori C, Atlas Network CG. Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas. Cell Syst 6(3):282-300.e2, 2018. e-Pub 2018. PMID: 29596783.
91. Ellrott K, Bailey MH, Saksena G, Covington KR, Kandoth C, Stewart C, Hess J, Ma S, Chiotti KE, McLellan M, Sofia HJ, Hutter C, Getz G, Wheeler D, Ding L, Group MC, Research Network CGA. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. Cell Syst 6(3):271-281.e7, 2018. e-Pub 2018. PMID: 29596782.
92. Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the Urethra. Hum Pathol 72:35-44, 2018. e-Pub 2018. PMID: 28827100.
93. Zhang S, Wang Y, Bondaruk J, Majewski T, Yao H, Lee S, Lee JG, Cogdell D, Lotan Y, Dinney C, Wei P, Baggerly K, Czerniak B. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test. Eur Urol Focus. e-Pub 2018. PMID: 29428551.
94. Murugan P, Rao P, Tamboli P, Czerniak B, Guo CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res 24(1):153-159, 2018. e-Pub 2018. PMID: 28429277.
95. van der Heijden AG, Mengual L, Ingelmo-Torres M, Lozano JJ, van Rijt-van de Westerlo CCM, Baixauli M, Geavlete B, Moldoveanud C, Ene C, Dinney CP, Czerniak B, Schalken JA, LALM K, Ribal MJ, Witjes JA, Alcaraz A. Urine cell-based DNA methylation classifier for monitoring bladder cancer. Clin Epigenetics 10:71, 2018. e-Pub 2018. PMID: 29854012.
96. Wang Z, Kim TB, Peng B, Karam J, Creighton C, Joon A, Kawakami F, Trevisan P, Jonasch E, Chow CW, Canales JR, Tamboli P, Tannir N, Wood C, Monzon F, Baggerly K, Varella-Garcia M, Czerniak B, Wistuba I, Mills G, Shaw K, Chen K, Sircar K. Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile and transcriptional landscape. Clin Cancer Res 23(21):6686-6696, 2017. e-Pub 2017. PMID: 28710314.
97. Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol 72(4):641-649, 2017. e-Pub 2017. PMID: 28601352.
98. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Network TR, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171(3):540-556.e25, 2017. e-Pub 2017. PMID: 28988769.
99. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney C. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus. e-Pub 2017. PMID: 28753816.
100. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget 8(21):34205-34222, 2017. e-Pub 2017. PMID: 27494900.
101. Fox MD, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Zhang L, Dinney CP, Czerniak B, Guo CC. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases. Am J Clin Pathol 147(5):500-506, 2017. e-Pub 2017. PMID: 28371875.
102. Fernández MI, Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU Int 119(5):684-691, 2017. e-Pub 2017. PMID: 27753185.
103. Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, Caraway NP, Huang L, Shoshan E, Velazquez-Torres G, Nitti G, Lee S, Lee JG, Fuentes-Mattei E, Willis D, Zhang L, Guo CC, Yao H, Baggerly K, Lotan Y, Lerner SP, Dinney C, McConkey D, Bar-Eli M, Czerniak B. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep 7:40714, 2017. e-Pub 2017. PMID: 28102366.
104. Ochoa AE, Choi W, Su X, Siefker-Radtke A, Czerniak B, Dinney C, McConkey DJ. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer. Oncotarget 7(49):80164-80174, 2016. e-Pub 2016. PMID: 27845906.
105. Yang J, Platt LT, Maity B, Ahlers KE, Luo Z, Lin Z, Chakravarti B, Ibeawuchi SR, Askeland RW, Bondaruk J, Czerniak BA, Fisher RA. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget 7(43):69159-69172, 2016. e-Pub 2016. PMID: 27713144.
106. Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine 12:105-117, 2016. e-Pub 2016. PMID: 27612592.
107. Guo CC, Dadhania V, Zhang L, Majewski T, Bondaruk J, Sykulski M, Wronowska W, Gambin A, Wang Y, Zhang S, Fuentes-Mattei E, Kamat AM, Dinney C, Siefker-Radtke A, Choi W, Baggerly KA, McConkey D, Weinstein JN, Czerniak B. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. Eur Urol 70(4):611-620, 2016. e-Pub 2016. PMID: 26988609.
108. Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 240(1):84-95, 2016. e-Pub 2016. PMID: 27287813.
109. Oshiro H, Czerniak BA, Sakamaki K, Tsuta K, Bondaruk J, Keyhani A, Dinney CP, Nagai T, Kamat AM. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study. Medicine (Baltimore) 95(31):e4500, 2016. e-Pub 2016. PMID: 27495099.
110. McConkey DJ, Choi W, Shen Y, Lee IL, Porten S, Matin SF, Kamat AM, Corn P, Millikan RE, Dinney C, Czerniak B, Siefker-Radtke AO. A prognostic gene expression signature in the molecular classification of chemotherapy-naïve urothelial cancer is predictive of clinical outcomes from neoadjuvant chemotherapy: a phase 2 trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with bevacizumab in urothelial cancer. Eur Urol 69(5):855-62, 2016. e-Pub 2016. PMID: 26343003.
111. Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdonà S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino A. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget 7(15):20636-54, 2016. e-Pub 2016. PMID: 26943042.
112. Research Network CGA, Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartle. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med 374(2):135-45, 2016. e-Pub 2016. PMID: 26536169.
113. Varkaris A, Corn PG, Parikh NU, Efstathiou E, Song JH, Lee YC, Aparicio A, Hoang AG, Gaur S, Thorpe L, Maity SN, Bar Eli M, Czerniak BA, Shao Y, Alauddin M, Lin SH, Logothetis CJ, Gallick GE. Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer. Clin Cancer Res 22(1):107-21, 2016. e-Pub 2016. PMID: 26272062.
114. Zhang L, Baladandayuthapani V, Zhu H, Baggerly KA, Majewski T, Czerniak BA, Morris JS. Functional CAR models for large spatially correlated functional datasets. J Am Stat Assoc 111(514):772-786, 2016. e-Pub 2016. PMID: 28018013.
115. Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol 46(12):1804-1814, 2015. e-Pub 2015. PMID: 26364859.
116. Sircar K, Yoo SY, Majewski T, Wani K, Patel LR, Voicu H, Torres-Garcia W, Verhaak RG, Tannir N, Karam JA, Jonasch E, Wood CG, Tamboli P, Baggerly KA, Aldape KD, Czerniak B. Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas. J Pathol Clin Res 1(4):212-24, 2015. e-Pub 2015. PMID: 27499906.
117. Singh RR, Murugan P, Patel LR, Voicu H, Yoo SY, Majewski T, Mehrotra M, Wani K, Tannir N, Karam JA, Jonasch E, Wood CG, Creighton CJ, Medeiros LJ, Broaddus RR, Tamboli P, Baggerly KA, Aldape KD, Czerniak B, Luthra R, Sircar K. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy. Mod Pathol 28(9):1225-35, 2015. e-Pub 2015. PMID: 26111976.
118. Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM. Clinical outcomes of cT1 micropapillary bladder cancer. J Urol 193(4):1129-34, 2015. e-Pub 2015. PMID: 25254936.
119. Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Am J Clin Pathol 142(6):864-871, 2014. e-Pub 2014. PMID: 25389341.
120. Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute forum. Urol Oncol 32(8):1108-1115, 2014. e-Pub 2014. PMID: 25443274.
121. Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, Biehl M, Seth S, Kaipparettu BA, Bristow CA, Donehower LA, Wallen EM, Smith AB, Tickoo SK, Tamboli P, Reuter V, Schmidt LS, Hsieh JJ, Choueiri TK, Hakimi AA, Research Network CGA, Chin L, Meyerson M, Kucherlapati R, Park WY, Robertson AG, Laird PW, Henske EP, Kwiatkowski DJ, Park PJ, Morgan M, Shuch B, Muzny D, Wheller DA, Linehan WM, Gibbs RA, Rathmell WK, Creighton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26(3):319-330, 2014. e-Pub 2014. PMID: 25155756.
122. Liang Y, Heitzman J, Kamat AM, Dinney CP, Czerniak B, Guo CC. Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol 45(7):1466-72, 2014. e-Pub 2014. PMID: 24745616.
123. Choi W, Czerniak B, Ochoa A, Su X, Siefker-Radtke A, Dinney C, McConkey DJ. Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. Nat Rev Urol 11(7):400-10, 2014. e-Pub 2014. PMID: 24960601.
124. Research Network TCGA. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315-322, 2014. e-Pub 2014. PMID: 24476821.
125. Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25(2):152-65, 2014. e-Pub 2014. PMID: 24525232.
126. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol 191(1):40-7, 2014. e-Pub 2014. PMID: 23911605.
127. Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GA. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ 20(12):1675-87, 2013. e-Pub 2013. PMID: 24037088.
128. Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet 45(12):1428-30, 2013. e-Pub 2013. PMID: 24121789.
129. Stanton ML, Xiao L, Czerniak BA, Guo CC. Urothelial Tumors of the Urinary Bladder in Young Patients: A Clinicopathologic Study of 59 Cases. Arch Pathol Lab Med 137(10):1337-1341, 2013. e-Pub 2013. PMID: 24079760.
130. Tarrant WP, Czerniak BA, Guo CC. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases. Hum Pathol 44(10):2220-2226, 2013. e-Pub 2013. PMID: 23856516.
131. Gust KM, McConkey DJ, Awrey S, Hegarty PK, Qing J, Bondaruk J, Ashkenazi A, Czerniak B, Dinney CP, Black PC. Fibroblast Growth Factor Receptor 3 is a Rational Therapeutic Target in Bladder Cancer. Mol Cancer Ther 12(7):1245-1254, 2013. e-Pub 2013. PMID: 23657946.
132. Research Network CGA. Comprehensive molecular characterization of clear cell renal cell carinoma. Nature 499(7456):43-49, 2013. e-Pub 2013.
133. Dayyani F, Czerniak BA, Sircar K, Munsell MF, Millikan RE, Dinney CP, Siefker-Radtke AO. Plasmacytoid Urothelial Carcinomas - A Chemo-sensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis. J Urol 189(5):1656-1661, 2013. e-Pub 2013. PMID: 23159581.
134. Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV. Genomic Variation by Whole-Genome SNP Mapping Arrays Predicts Time-to-Event Outcome in Patients with Chronic Lymphhocytic Leukemia: A Comparison of CLL and HapMap Genotypes. J Mol Diagn 15(2):196-209, 2013. e-Pub 2013. PMID: 23273604.
135. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of miR205. J Biol Chem 288(5):3275-88, 2013. e-Pub 2013. PMID: 23239884.
136. Alexandrescu S, Tatevian N, Czerniak BA, Covinsky MH, Burns NK, Brown RE. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis. Int J Clin Exp Pathol 5(6):503-11, 2012. e-Pub 2012. PMID: 22949932.
137. Guo CC, Wang Y, Xiao L, Troncoso P, Czerniak BA. The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers. Hum Pathol 43(5):644-9, 2012. e-Pub 2012. PMID: 21937078.
138. Akli S, Zhang XQ, Bondaruk J, Tucker SL, Czerniak BA, Benedict WF, Keyomarsi K. Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer. Cell Cycle 11(7):1468-76, 2012. e-Pub 2012. PMID: 22441703.
139. Majewski T, Spiess PE, Bondaruk J, Black P, Clarke C, Benedict W, Dinney CP, Grossman HB, Tang KS, Czerniak B. Detection of bladder cancer using proteomic profiling of urine sediments. PLoS One 7(8):e42452, 2012. e-Pub 2012. PMID: 22879988.
140. Lee S, Lee I, Jung Y, McConkey D, Czerniak B. In-frame cDNA library combined with protein complementation assay identifies ARL11-binding partners. PLoS One 7(12):e52290, 2012. e-Pub 2012. PMID: 23272234.
141. Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CC. Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol 42(11):1792-8, 2011. e-Pub 2011. PMID: 21733553.
142. Sabichi AL, Lee JJ, Grossman HB, Liu S, Richmond E, Czerniak BA, De la Cerda J, Eagle C, Viner JL, Palmer JL, Lerner SP. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila) 4(10):1580-9, 2011. e-Pub 2011. PMID: 21881030.
143. Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev 20(7):1483-1491, 2011. e-Pub 2011. PMID: 21586619.
144. Kumar R, Deavers MT, Czerniak BA, Madewell JE. Intraosseous hibernoma. Skeletal Radiol 40:641-645, 2011. e-Pub 2011. PMID: 21207023.
145. Duzkale H, Schweighofer C, Coombes KR, Barron LL, Ferrajoli A, O'Brien S, Wierda WG, Pfeifer J, Majewski T, Czerniak BA, Jorgensen JL, Medeiros LJ, Freireich EJ, Keating MJ, Abruzzo LV. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts over-all survival in untreated patients. Blood 117(15):4076-4084, 2011. e-Pub 2011. PMID: 21310924.
146. Diao L, Clarke CH, Coombes KR, Hamilton SR, Roth J, Mao L, Czerniak B, Baggerly KA, Morris JS, Fung ET, Bast RC. Reproducibility of SELDI Spectra Across Time and Laboratories. Cancer Inform 10:45-64, 2011. e-Pub 2011. PMID: 21552492.
147. Mirriman DJ, Deavers MT, Czerniak B, Lin PP. Massive desmoplastic fibroblastoma with scapular invasion – A case report. Orthopedics 33(8), 2010. e-Pub 2010. PMID: 20704102.
148. Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res. e-Pub 2010. PMID: 20716667.
149. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak B, Guo CC. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol 41(6):832-837, 2010. e-Pub 2010. PMID: 20153508.
150. Nicolas MM, Tamboli P, Gomez JA, Czerniak B. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol 41(5):663-671, 2010. e-Pub 2010. PMID: 20004935.
151. Inamoto T, Czerniak B, Dinney CP, Kamat AM. Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer 116(2):340-346, 2010. e-Pub 2010. PMID: 19908257.
152. Dancer JY, Henry SP, Bondaruk J, Lee SK, Ayala AG, Crombrugghe D, Czerniak B. Expression of Master Regulatory Genes Controlling Skeletal Development in Benign Cartilage and Bone Forming Tumors. Hum Pathol 41(12):1788-1793, 2010. e-Pub 2010. PMID: 21078438.
153. Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak B, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 42(1):146-150, 2010. e-Pub 2010. PMID: 20971497.
154. Guo CC, Dancer JY, Wang Y, Aparicio A, Navone NM, Troncoso P, Czerniak B. TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Hum Pathol 42(1):11-17, 2010. e-Pub 2010. PMID: 21040948.
155. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Jr AG, Rrd G, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Tudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, Garcia-Prats M, Valdivia G, Porru S, Benhamou S, Hoover RN, Jr FJ, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42(11):978-984, 2010. e-Pub 2010.
156. Guo CC, Gomez E, Tamboli P, Bondaruk J, Kamat A, Bassett R, Dinney CP, Czerniak B. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol 40(10):1448-1452, 2009. e-Pub 2009. PMID: 19454359.
157. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KKH, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nature Genetics 41(9):991-995, 2009. e-Pub 2009. PMID: 19648920.
158. Guo CC, Zuo G, Cao D, Troncoso P, Czerniak B. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol 22(7):866-871, 2009. e-Pub 2009. PMID: 19396154.
159. Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Testicular Germ Cell Tumors With Sarcomatous Components: An Analysis of 33 Cases. Am J Surg Pathol 33(8):1173-1178, 2009. e-Pub 2009. PMID: 19561445.
160. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak B, Do KA, Wu KJ, Marlow LA, Wood CG, Copland JA, Walker CL. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res 15(1):81-90, 2009. e-Pub 2009. PMID: 19118035.
161. Guo CC, Tamboli P, Czerniak B. Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med 133(1):62-66, 2009. e-Pub 2009. PMID: 19123738.
162. Wang WL, Mayordomo E, Czerniak B, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, Lopez-Terrada D, Lazar AJ. Fluorescence in situ Hybridization is a Useful Ancillary Diagnostic Tool for Extraskeletal Myxoid Chondrosarcoma. Mod Pathol 21(11):1303-1310, 2008. e-Pub 2008. PMID: 18587326.
163. Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Elias KJ, Lotan Y, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B. Quantitation of aurora kinase A gene copy number in urine sediments and bladder cancer detection. JNCI 100(19):1401-1411, 2008. e-Pub 2008. PMID: 18812553.
164. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, Caballero OL, Westra WH, Sidransky D, Hoque MO. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev 17(10):2786-2794, 2008. e-Pub 2008. PMID: 18843024.
165. Tsao CC, Teh BT, Jonasch E, Shreiber-Agus N, Efstathiou E, Hoang A, Czerniak B, Logothetis C, Corn PG. Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. Cancer Biol Ther 7(10):1619-1627, 2008. e-Pub 2008. PMID: 19018165.
166. Shivapurkar N, Stastny V, Okumura N, Girard L, Xie Y, Prinsen C, Thunnissen FB, Wistuba II, Czerniak B, Frenkel E, Roth JA Liloglou T, Xinarianos G, Field JK, Minna JD, Gazdar AF. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. Cancer Res 68(18):7448-7456, 2008. e-Pub 2008. PMID: 18794132.
167. Majewski T, Lee S, Jeong J, Yoon DS, Kram A, Kim MS, Tuziak T, Bondaruk J, Lee S, Park WS, Tang KS, Chung W, Shen L, Ahmed SS, Johnston DA, Grossman HB, Dinney CP, Zhou JH, Harris RA, Snyder C, Filipek S, Narod SA, Watson P, Lynch HT, Gazdar A, Bar-Eli M, Wu XF, McConkey DJ, Baggerly K, Issa JP, Benedict WF, Scherer SE, Czerniak B. Understanding the development of human bladder cance by using a whole-organ genomic mapping strategy. Lab Invest 88(7):694-721, 2008. e-Pub 2008. PMID: 18458673.
168. Ricketts R, Tamboli P, Czerniak B, Guo CC. Tumor-to-Tumor Metastasis: Report of 2 Cases of Metastatic Carcinoma to Angiomyolipoma of the Kidney. Arch Pathol Lab Med 132(6):1016-1020, 2008. e-Pub 2008. PMID: 18517262.
169. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF. Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol Biomarkers Prev 17(4):995-1000, 2008. e-Pub 2008. PMID: 18398044.
170. Harris LD, La Cerda JD, Tuziak T, Rosen D, Xiao L, Shen Y, Sabichi AL, Czerniak B, Grossman HB. Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. Mol Carcinog 47(9):678-685. e-Pub 2008. PMID: 18288642.
171. Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, Grossman HB, Ayala AG, Czerniak B. Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol 38:753-761, 2007. e-Pub 2007. PMID: 17306332.
172. Spiess PE, Kassouf W, Tuziak T, Tibbs R, Hernandez M, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Review of the M.D. Anderson experience in the management of bladder sarcoma. Urol Oncol 25:38-45, 2007. e-Pub 2007. PMID: 17208137.
173. Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a comtemporary review of The University of Texas M. D. Anderson Cancer Center experience. Cancer 110(4):764-769, 2007. e-Pub 2007. PMID: 17614317.
174. Lee S, Jeong J, Majewski T, Scherer S, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess PE, Wu X, Filipek S, McConkey D, Bar-Eli M, Issa JP, Benedict WF, Czerniak B. Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. PNAS 104(34):13732-13737, 2007. e-Pub 2007. PMID: 17702869.
175. Katayama H, Sasai K, Czerniak BA, Carter JL, Sen S. Aurora-A kinase phosphorylation of Aurora-A interacting protein (AIP) and stabilization of the enzyme-substrate complex. J Cell Biochem 102(5):1318-1331, 2007. e-Pub 2007. PMID: 17957726.
176. Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP. Distinctive expression pattern of ErbB Family Receptors signifies an aggressive variant of bladder cancer. J Urol 179(1):353-358, 2007. e-Pub 2007. PMID: 18006009.
177. Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Predictors of outcome in patients undergoing postchemotherapy retroperitonial lymph node dissection for testicular cancer. Cancer 107:1483-1490, 2006. e-Pub 2006. PMID: 16944541.
178. Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: Implications for therapy. Clin Cancer Res 12:4671-4677, 2006. e-Pub 2006. PMID: 16899617.
179. Kim MS, Jeong J, Majewski T, Kram A, Yoon DS, Zhang RD, Li JZ, Ptaszynski K, Kuang TC, Zhou JH, Sathyanarayana UG, Tuziak T, Johnston DA, Grossman HB, Gazdar AF, Scherer SE, Benedict WF, Czerniak B. Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia. Lab Invest 86(2):175-190, 2006. e-Pub 2006. PMID: 16402033.
180. Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CPN, Grossman HB. Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?. Urology 67(3):466-471, 2006. e-Pub 2006. PMID: 16527559.
181. Tuziak T, Jeong J, Majewski T, Kim MS, Steinberg J, Wang Z, Yoon DS, Kuang TC, Baggerly K, Johnston D, Czerniak B. High-resolution whole-organ mapping with SNPs and its significance to early events in carcinogenesis. Lab Invest 85(5):689-701, 2005. e-Pub 2005. PMID: 15908911.
182. Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak B. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest 85(4):532-549, 2005. e-Pub 2005. PMID: 15778693.
183. Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer 113(4):600-604, 2005. e-Pub 2005. PMID: 15472908.
184. Spiess PE, Czerniak B. Malignant Mesothelioma of the Tunica Vaginalis. Urology 66(2):397-401, 2005. e-Pub 2005. PMID: 16040098.
185. Huo L, Lai S, Gladish G, Czerniak B, Moran CA. Pulmonary artery angiosarcoma: A clinicopathologic and radiological correlation. Ann Diagn Pathol 9(4):209-214, 2005. e-Pub 2005. PMID: 16084454.
186. Shao L, Lerner SL, Bondaruk J, Czerniak BA, Zeng X, Grossman HB, Spitz MR, Wu X. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer 41(4):379-389, 2004. e-Pub 2004. PMID: 15390184.
187. Sathyanarayana UG, Maruyama R, Padar A, Suzuki M, Bondaruk J, Sagalowsky A, Minna JD, Frenkel EP, Grossman HB, Czerniak B, Gazdar AF. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res 64(4):1425-1430, 2004. e-Pub 2004. PMID: 14973053.
188. Slaton JW, Millikan R, Inoue K, Karashima T, Czerniak B, Shen Y, Yang Y, Benedict WF, Dinney CP. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J Urol 171(2 Pt 1):570-574, 2004. e-Pub 2004. PMID: 14713761.
189. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Arlinghaus RB, Czerniak BA, Sen S. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 36(1):55-62, 2004. e-Pub 2004. PMID: 14702041.
190. Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34(3):263-269, 2003. e-Pub 2003. PMID: 12673561.
191. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst 94(17):1320-1329, 2002. e-Pub 2002. PMID: 12208897.
192. Yamashita M, Rosser CJ, Zhou JH, Zhang XQ, Connor RJ, Engler H, Maneval DC, Karashima T, Czerniak BA, Dinney CP, Benedict WF. Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer. Cancer Gene Ther 9(8):687-691, 2002. e-Pub 2002. PMID: 12136430.
193. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, Farinas AJ, Vakar-Lopez F, Sagalowsky A, Czerniak B, Gazdar AF. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 61(24):8659-8663, 2001. e-Pub 2001. PMID: 11751381.
194. Merchant SH, Amin MB, Tamboli P, Ro J, Ordonez NG, Ayala AG, Czerniak BA, Ro JY. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol 25(12):1515-1519, 2001. e-Pub 2001. PMID: 11717541.
195. Yoon DS, Li L, Zhang RD, Kram A, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B. Genetic mapping and DNA sequence-based analysis of loci on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Oncogene 20(36):5005-5014, 2001. e-Pub 2001. PMID: 11526485.
196. Kram A, Li L, Zhang RD, Yoon DS, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B. Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression. Lab Invest 81(7):1039-1048, 2001. e-Pub 2001. PMID: 11454992.
197. Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 8(1):9-15, 2001. e-Pub 2001. PMID: 11115562.
198. Hoang MP, Ayala AG, Suarez PA, Ordonez NG, Czerniak B. Mesenchymal Chondrosarcoma: A Small Cell Neoplasm with Polyphenotypic Differentiation. Int J Surg Pathol 8(4):291-301, 2000. e-Pub 2000. PMID: 11494006.
199. Hackel CG, Krueger S, Grote HJ, Oshiro Y, Hodges S, Johnston DA, Johnson ME, Roessner A, Ayala AG, Czerniak B. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk for recurrence and metastasis in chondrosarcoma. Cancer 89(5):995-1003, 2000. e-Pub 2000. PMID: 10964329.
200. Haeckel C, Krueger S, Kuester D, Ostertag H, Samii M, Buehling F, Broemme D, Czerniak B, Roessner A. Expression of cathepsin K in chordoma. Hum Pathol 31(7):834-840, 2000. e-Pub 2000. PMID: 10923921.
201. Czerniak B, Li L, Chaturvedi V, Johnston DA, Ro J, Logothetis C, von Eschenback AC. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 27(4):392-402, 2000. e-Pub 2000. PMID: 10719370.
202. Vakar-Lopez F, Ayala AG, Raymond AK, Czerniak B. Epithelial Phenotype in Ewing's Sarcoma and Primitive Neuroectodermal Tumor. Int J Surg Pathol 8(1):59-65, 2000. e-Pub 2000. PMID: 11493965.
203. Benedict WF, Lerner SP, Shen X, Green A, Zhou J, Czerniak B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer: prognostic implications. Oncogene 18(5):1197-1203, 1999. e-Pub 1999. PMID: 10022125.
204. Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Pugh WC, Logothetis C, Von Eschenbach AC, Grossman HB, Batsakis JG. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 18(5):1185-1196, 1999. e-Pub 1999. PMID: 10022124.
205. Häckel C, Ayala AG, Radig K, Raymond AK, Roessner A, Czerniak B. Protease expression in dedifferentiated parosteal osteosarcoma. Arch Pathol Lab Med 123(3):213 – 221, 1999. e-Pub 1999. PMID: 10086509.
206. Oshiro Y, Chaturvedi V, Hayden D, Nazeer T, Johnson M, Johnston DA, Ordonez NG, Ayala AG, Czerniak B. Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer 83(11):2324-2334, 1998. e-Pub 1998. PMID: 9840532.
207. Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 39(3):687-695, 1997. e-Pub 1997. PMID: 9336151.
208. Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res 3(10):1823-1829, 1997. e-Pub 1997. PMID: 9815569.
209. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene 14(17):2059-2070, 1997. e-Pub 1997. PMID: 9160886.
210. Hackel C, Czerniak B, Ayala AG, Radig K, Roessner A. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma. Cancer 79(1):53-58, 1997. e-Pub 1997. PMID: 8988726.
211. Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NH, Meyn RE. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 35(2):281-287, 1996. e-Pub 1996. PMID: 8635934.
212. Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology 47(3):305-310, 1996. e-Pub 1996. PMID: 8633392.
213. Cook P, Czerniak B, Chan JK, Mackay B, Ordonez NG, Ayala AG, Rosai J. Nodular spindle-cell vascular transformation of lymph nodes: A benign process occurring predominantly in retroperitoneal lymph nodes draining carcinomas that can simulate Kaposi's sarcoma or metastatic tumor. Am J Surg Pathol 19(9):1010-1020, 1995. e-Pub 1995. PMID: 7661274.
214. Simms WW, Ordonez NG, Johnston D, Ayala AG, Czerniak B. p53 expression in dedifferentiated chondrosarcoma. Cancer 76(2):223-227, 1995. e-Pub 1995. PMID: 8625095.
215. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD. p53 expression and DNA ploidy of cartilage lesions. Hum Pathol 26(6):620-624, 1995. e-Pub 1995. PMID: 7774891.
216. Koss L, Czerniak B, Herz F, Deitch D, Etkind PR, Alster P, Puszkin E, Alexander J, Wersto R. Estrogen receptor and oncogene expression in human mammary carcinomas. Surg Pathol 5:349-369, 1995. e-Pub 1995.
217. Dorfman H, Czerniak B. Bone Cancers. Cancer 75(1 Suppl):203-210, 1995. e-Pub 1995. PMID: 8000997.
218. Czerniak B, Rosai J. Role of cytology in intraoperative diagnosis. A practical guide. Pathol Annu 30:83-102, 1995. e-Pub 1995. PMID: 8570281.
219. Ooi A, Herz F, Ii S, Cordoncardo C, Fradet Y, Mayall B, Bladder TNN. Ha-ras codon 12 mutation in papillary tumors of the urinary-bladder - a retrospective study. Int J Oncol 4(1):85-90, 1994. e-Pub 1994. PMID: 21566894.
220. Czerniak B, Herz F, Wersto RP, Koss LG. Asymmetric distribution of oncogene products at mitosis. Proc Natl Acad Sci U S A 89(11):4860-4863, 1992. e-Pub 1992. PMID: 1350677.
221. Czerniak B, Cohen G, Deitch D, Simmons H, Etkind P, Herz F, Koss LG. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol 23(11):1199-1204, 1992. e-Pub 1992. PMID: 1427748.
222. Koss LG, Czerniak B. Image analysis and flow cytometry of tumors of prostate and bladder with a comment on molecular biology of urothelial tumors. Monogr Pathol 34:112-128, 1992. e-Pub 1992. PMID: 1406738.
223. Herz F, Czerniak B, Deitch D, Wersto RP, Simmons DA, Koss LG. Protein expression in relation to the cell cycle of exponentially growing human prostatic epithelial cells. Cell Prolif 24(3):321-330, 1991. e-Pub 1991. PMID: 2039807.
224. Czerniak B, Deitch D, Simmons H, Herz F, Koss LG, Etkind P. Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br J Cancer 62(5):762-763, 1990. e-Pub 1990. PMID: 2245167.
225. Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Schwartz E, Koss LG. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J Histochem Cytochem 38(4):463-466, 1990. e-Pub 1990. PMID: 1969431.
226. Czerniak B, Rojas-Corona RR, Dorfman HD. Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer 64(11):2319-2334, 1989. e-Pub 1989. PMID: 2804923.
227. Czerniak B, Herz F, Gorczyca W, Koss LG. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer 64(7):1467-1473, 1989. e-Pub 1989. PMID: 2550123.
228. Czerniak B, Chen R, Tuziak T, Markiewski M, Kram A, Gorczyca W, Deitch D, Herz F, Koss LG. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas. Cancer 63(10):2008-2013, 1989. e-Pub 1989. PMID: 2467732.
229. Koss LG, Czerniak B, Herz F, Wersto RP. Flow Cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol 20(6):528-548, 1989. e-Pub 1989. PMID: 2470666.
230. Czerniak B, Tuziak T, Markiewski M, Kram A, Gorczyca W, Herz F, Koss LG. Expression of ras oncogenes in early and advanced breast cancer in women. Nowotwory 38(3):145-151, 1988. e-Pub 1988. PMID: 3072522.
231. Czerniak B, Eppich EM, Gorczyca W, Herz F, Koss LG. Cytometric measurements of DNA ploidy in cancer of the large intestine. Patol Pol 39(1):1-12, 1988. e-Pub 1988. PMID: 3412818.
232. Gorczyca W, Lubinski J, Czerniak B. Lymphoma of the breast detected by cytological examination. Patol Pol 39(1):66-70, 1988. e-Pub 1988. PMID: 3412823.
233. Czerniak B, Gorczycz W, Lubinski J. Fine needle aspiration cytology of breast lymphoma (in Polish). Pat Pol 33:66-67, 1988. e-Pub 1988.
234. Czerniak B, Herz F, Koss LG, Schlom J. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas. Cancer 60(10):2432-2435, 1987. e-Pub 1987. PMID: 3311346.
235. Czerniak B, Herz F, Wersto RP, Koss LG. Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29. Cancer Res 47(11):2826-2830, 1987. e-Pub 1987. PMID: 3105868.
236. Czerniak B, Herz F, Wersto RP, Koss LG. Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells. Am J Pathol 126(3):411-416, 1987. e-Pub 1987. PMID: 3548406.
237. Czerniak B, Herz F, Koss LG. DNA distribution patterns in early gastric carcinomas. A Feulgen cytometric study of gastric brush smears. Cancer 59(1):113-117, 1987. e-Pub 1987. PMID: 2431753.
238. Woyke S, Gorczyca W, Czerniak B, Depczynska A, Marlicz K. Use of cytological methods in the diagnosis of cancer of the esophagus and cardia. Nowotwory 36(2):98-105, 1986. e-Pub 1986. PMID: 3786167.
239. Czerniak B. Distribution of the surface coat on the mesothelial and cancer cells from human effusions. Materia Med Polona 16:3-7, 1986. e-Pub 1986.
240. Czerniak B, Czerniak E, Marzecki Z. Usefulness of fine-needle aspiration biopsy of lymph nodes in the diagnosis of Hodgkin's disease. Nowotwory 36(1):12-16, 1986. e-Pub 1986. PMID: 3786153.
241. Czerniak B, Woyke S, Marlicz K. Cytodiagnosis of early stomach cancer. Patol Pol 37(1):1-7, 1986. e-Pub 1986. PMID: 3029654.
242. Czerniak B, Woyke S, Daniel B, Krzysztolik Z, Koss LG. Diagnosis of orbital tumors by aspiration biopsy guided by computerized tomography. Cancer 54(11):2385-2389, 1985. e-Pub 1985. PMID: 6498730.
243. Czerniak B, Woyke S, Marlicz K. Cytological-histological correlations in stomach cancer. Patol Pol 36(3):217-228, 1985. e-Pub 1985. PMID: 3012446.
244. Czerniak B, Papenhausen PR, Herz F, Koss LG. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody. Cancer 55(12):2783-2788, 1985. e-Pub 1985. PMID: 3888371.
245. Czerniak B, Koss LG. Expression of Ca antigen on human urinary bladder tumors. Cancer 55(10):2380-2383, 1985. e-Pub 1985. PMID: 3886123.
246. Czerniak B, Darzynkiewicz Z, Staiano-Coico L, Herz F, Koss LG. Expression of Ca antigen in relation to cell cycle in cultured human tumor cells. Cancer Res 44(10):4342-4346, 1984. e-Pub 1984. PMID: 6432310.
247. Czerniak B, Koss LG, Sherman A. Nuclear pores and DNA ploidy in human bladder carcinomas. Cancer Res 44(9):3752-3756, 1984. e-Pub 1984. PMID: 6744293.
248. Czerniak B, Marlicz K. Surface coat of enterocytes in chronic duodenitis. Mater Med Polona 16(1):9-14, 1984. e-Pub 1984. PMID: 6527574.
249. Czerniak B. Ultrastructure of the surface coat of the mesothelial and cancer cells from human effusions. Mater Med Pol 16(1):3-7, 1984. e-Pub 1984. PMID: 6527570.
250. Czerniak B, Krzysztolik Z, Woyke S, Domagala W. Fine needle aspiration cytology of intraocular malignant melanoma. Acta Cytol 27(2):157-165, 1983. e-Pub 1983. PMID: 6573087.
251. Kowalik L, Czerniak B. Ultrastructure of salivary gland pleomorphic adenoma (In Polish). Otol Pol 37:472-475, 1983. e-Pub 1983.
252. Starzynska T, Marlicz K, Depczynska A, Woyke S, Czerniak B. Endoscopy with guided biopsy and cytological examination in the preoperative diagnosis of cancer of the upper digestive tract. Pol Arch Med Wewn 69(1):47-51, 1983. e-Pub 1983. PMID: 6193500.
253. Krzystolik Z, Czerniak B, Woyke S. Diagnosis of intraocular melanoma by thin-needle aspiration biopsy. Klin Oczna 84(9):279-282, 1982. e-Pub 1982. PMID: 7162114.
254. Czerniak B, Woyke S, Lukaszyk I. The intercellular junctions of the cancer cells from human effusions. Acta Med Pol 22(3):217-229, 1981. e-Pub 1981. PMID: 7348091.
255. Woyke S, Domagala W, Czerniak B, Strokowska M. Fine needle aspiration cytology of malignant melanoma of the skin. Acta Cytol 24(6):529-538, 1980. e-Pub 1980. PMID: 6934680.
256. Czerniak B, Woyke S. The intercellular junctions of the cancer cells from human effusions. Electron Microscopy 2:440-441, 1980. e-Pub 1980.
257. Lubinski J, Woyke S, Czerniak B. Concanavalin A distribution on the surface of the mesothelial and cancer cells from human effusions. Electron and fluorescent microscopic observations. Acta Med Pol 21(4):377-378, 1980. e-Pub 1980. PMID: 7246250.
258. Czerniak B, Woyke S. Cell surface material of the mesothelial and cancer cells from human effusions. Acta Med Pol 21(4):313-314, 1980. e-Pub 1980. PMID: 6166152.
259. Marlicz K, Czerniak B, Szymanski Z. Duodenitis diagnosed by means of duodenoscopy: personal observations. Pol Arch Med Wewn 61(3):187-194, 1979. e-Pub 1979. PMID: 440987.
260. Domagala W, Czerniak B, Woyke S. Distribution of surface coat on human cancer cells from body cavity fluids. A scanning electron microscopic study. Acta Med Pol 20(4):377-378, 1979. e-Pub 1979. PMID: 546091.
261. Lubinski J, Czerniak B. Distribution and movement of concanavalin-A receptors on the surface of cancer cells from human effusions. Acta Med Pol 20(4):429-430, 1979. e-Pub 1979. PMID: 546110.
262. Woyke S, Czerniak B, Lukaszyk I. Changes in tight junction of the cancer cells from human effusions. Acta Med Pol 20(4):475-476, 1979. e-Pub 1979. PMID: 546123.
263. Woyke S, Czerniak B, Lukaszyk I. Application of freeze-fractured replicas for evaluation of nuclear envelope of malignant cells from the human effusions. Acta Med Pol 20(4):477-478, 1979. e-Pub 1979. PMID: 546124.
264. Woyke S, Czerniak B. Fine Needle Aspiration Cytology of Metastatic Myxopapillary Ependymoma. Acta Med Pol 20(1):47-48, 1979. e-Pub 1979. PMID: 495211.
265. Czerniak B. Ultrastructure of cells from fluids in human serous cavities. Study of the external covering (glycocalix) as well as of flattening and spreading of the cells. Ann Acad Med Stetin 24:565-583, 1978. e-Pub 1978. PMID: 742756.
266. Czerniak B. Spreading and surface coat of benign and malignant cells from human effusions. Ann Acad Med St 24:555-585, 1978. e-Pub 1978.
267. Woyke S, Czerniak B. The morphology of cells in effusions settled on glass. Acta Cytol 21(4):508-513, 1977. e-Pub 1977. PMID: 269599.
268. Woyke S, Czerniak B. The surface coat of the human effusion cells. Acta Cytol 21(3):447-454, 1977. e-Pub 1977. PMID: 268128.
269. Woyke S, Czerniak B. The surface coat of human effusion cells. Acta Med Pol 18(4):379-380, 1977. e-Pub 1977. PMID: 76418.
270. Czerniak B, Mietkiewski J, Mazuryk R. Effect of methotrexate on growth kinetics in Ehrlich's carcinoma. Patol Pol 27(3):219-230, 1976. e-Pub 1976. PMID: 967534.
271. Steinmetz AR, Pierce M, Martini A, Tholomier C, Manyam G, Chen Y, Sood A, Duplisea JJ, Johnsonrd BA, Czerniak BA, Lee BH, Jagannath C, Yla-Herttuala S, Parker NR, McConkey DJ, Dinney CP, Mokkapati S. Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon a gene therapy in a murine bladder cancer model. Frontiers in Immunology.

Book Chapters

1. McConkey, DJ, Mendelsohn, C, Lee, B, Dinney, CP, Czerniak, BA. Molecular Pathogenesis, 221-238, 2025.
2. Guo CC, Ro JY, Czerniak B. Invasive Urothelial Carcinoma with Molecular Types. In: Urinary Bladder Pathology. Springer International Publishing, 45-61, 2021.
3. Siefker-Radtke AO, Czerniak B, Dinney C. Chapter 36: Bladder Cancer. In: The MD Anderson Manual of Medical Oncology. 3rd. The McGraw Hills Companies, Inc, 753-771, 2016.
4. Siefker-Radtke A, Dinney CPN, Czerniak B, Millikan RE, McConkey DJ. Chapter 33: Bladder Cancer. In: The MD Anderson Manual of Medical Oncology. 2nd. McGraw Hill, 925-943, 2011.
5. Czerniak B. Molecular Pathology and Biomarkers of Bladder Cancer. In: Cancer Biomark. 1-6, 159-76, 2011.
6. Powers M, Zhang W, Lopez-Terrada D, Czerniak BA, Lazar AJ. The Molecular Pathology of Sarcomas. In: Cancer Biomark. 1-6, 475-91, 2011.
7. Czerniak B. Incipient Events in Human Carcinogenesis: A Concept of Forerunner Genes. In: Regulation of Gene Expression in the Tumor Environment. Springer, 125-146, 2008.
8. Czerniak B, Tuziak T. Soft Tissue Lesions. In: Diagnostic Cytopathology. 5th. Lippincott Williams & Wilkins, 1302-1339, 2006.
9. Czerniak B, Tuziak T, Kram A, Ayala AG. Bone Tumors. In: Diagnostic Cytopathology & its Histopathologic Bases. 5th. Lippincott Williams & Wilkins, 1340-1373, 2006.
10. Siefker-Radtke AO, Dinney CPN, Czerniak B, Millikan RE. Bladder Cancer. In: The MD Anderson Manual of Medical Oncology. The McGraw-Hill Comapnies, Inc, 739-756, 2006.
11. Czerniak BA. Pathologic and Molecular Aspects of Soft Tissue Sarcomas. In: Surgical Oncology Clinics of North America. 12. Elsevier Science, 263-303, 2003.
12. Czerniak B, Kram A. Pathology of Soft Tissue Sarcomas. In: American Cancer Society, Atlas of Clinical Oncology; Soft Tissue Sarcomas. B.C. Decker Inc, 11-42, 2002.
13. Dorfman HD, Czerniak B, Kotz R, Vanel D, Park YK, Unni KK. Epidemiology, clinical features, histopathological typing and grading of bone tumors. In: World Health Organization Classification of Tumors, Pathology & Genetics, Tumors of Soft Tissue and Bone. Oxford University Press, 227-232, 2002.
14. Ayala AG, Czerniak B, Raymond AK, Knuutila S. Periosteal Osteosarcoma. In: World Health Organization Classification of Tumors, Pathology & Genetics, Tumors of Soft Tissue and Bone. Oxford University Press, 282-283, 2002.
15. Ayala AG, Ro JY, Amin M, Czerniak B, Albores-Saavedra J. Urinary Bladder. In: Pathology of the Incipient Neoplasia. Oxford University Press, 489-534, 2001.
16. Ayala AG, Czerniak B, Ro JY. Incipient Neoplasms of the Prostate. ed. Henson, Albores-Saavedra. In: The Pathology of Incipient Neoplasia, Chapter 21. Oxford University Press, 535-569, 2001.
17. Haeckel C, Grote HJ, Grote HJ, Oshiro Y, Ayala A, Czerniak B, Roessner A. Expression of Proteolytic Enzymes in Chondrosarcoma. In: Soft Tissue Tumors, 1998.
18. Czerniak B, Herz F. Molecular Biology of Common Genito-Urinary Tumors. In: Diagnostic Cytology of The Urinary Tract, Chapter 11. Lippincott-Raven, 345-364, 1995.
19. Koss LG, Czerniak B. Image Analysis and Flow Cytometry of Tumors of the Prostate and Bladder: With a Comment in Molecular Biology of Urothelial Tumors. In: Weinstein, R.S. and Gardner, W.A. Jr. Pathology and Pathobiology of the Urinary Bladder and Prostate, Chapter 5. Williams & Wilkins, Baltimore, 112-128, 1992.

Books (edited and written)

1. Czerniak B. Dorfman & Czerniak's Bone Tumors. Ed(s) 2. Elsevier, 2016.
2. Dorfman H, Czerniak B. Bone Tumors, Textbook of skeletal pathology. Mosby-Year Book, Inc, 1999.

Patents

1. Czerniak B, Grossman H, Sen S. Non-invasive Detection of Bladder Cancer By Fluorescence in situ Hybridization of Aurora A. Patent Number: PCT/US2008/013632.
2. Chung W, Czerniak B, Issa J. Detection of Bladder Cancer. Patent Number: 8609343.
3. Czerniak B, Baggerly K, Bondaruk J, Majewski T, Dinney C, Zhang S, Wang Y. Multi-Color FISH Test for Bladder Cancer Detection. Patent Number: 16/965,409.
4. McConkey D, Dinney C, Czerniak B, Baggerly K, Tran M, Choi W, Navai N, Adam L, Siefker-Radtke A, Wszolek M. Methods of Characterizing and Treating Molecular Subset of Muscle-Invasive Bladder Cancer. Patent Number: 14/647,587.
5. Czerniak B, Johnston D. Methods of Detecting, Diagnosing, and Treating Cancer and Identifying Neoplastic Progression. Patent Number: 10167241.